Nissan Chemical Corporation (TYO:4021)
Japan · Delayed Price · Currency is JPY 7,976.00
-67.00 (-0.83%)
Aug 14, 2026, 3:30 PM JST
Nissan Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 288,507 | 279,586 | 251,365 | 226,705 | 228,065 | 207,972 | |
Revenue Growth | 9.89% | 11.23% | 10.88% | -0.60% | 9.66% | -0.55% |
Cost of Revenue | 151,834 | 148,647 | 134,823 | 121,930 | 121,262 | 106,883 |
Gross Profit | 136,673 | 130,939 | 116,542 | 104,775 | 106,803 | 101,089 |
Selling, General & Admin | 69,312 | 56,297 | 51,620 | 47,107 | 45,296 | 41,219 |
Research & Development | - | 5,461 | 4,857 | 5,153 | 5,149 | 5,052 |
Operating Expenses | 69,312 | 67,387 | 59,708 | 56,572 | 54,519 | 50,129 |
Operating Income | 67,361 | 63,552 | 56,834 | 48,203 | 52,284 | 50,960 |
Interest Expense | -441 | -396 | -709 | -526 | -252 | -73 |
Interest & Investment Income | 2,110 | 1,756 | 1,941 | 1,721 | 1,526 | 817 |
Earnings From Equity Investments | 1,678 | 1,507 | 1,061 | 536 | 1,485 | 950 |
Currency Exchange Gain (Loss) | 1,712 | 613 | -153 | 2,210 | 1,296 | 1,134 |
Other Non Operating Income (Expenses) | 397 | 24 | -82 | 428 | 275 | 699 |
EBT Excluding Unusual Items | 72,817 | 67,056 | 58,892 | 52,572 | 56,614 | 54,487 |
Gain (Loss) on Sale of Investments | -78 | - | 1,247 | 979 | 811 | 2,263 |
Gain (Loss) on Sale of Assets | -1,129 | -1,160 | -873 | -945 | -822 | -798 |
Asset Writedown | - | - | -3,876 | -823 | - | - |
Other Unusual Items | -209 | - | 4,081 | - | - | -1,793 |
Pretax Income | 71,401 | 65,896 | 59,471 | 51,783 | 56,603 | 54,159 |
Income Tax Expense | 17,962 | 15,398 | 16,520 | 13,578 | 15,187 | 15,026 |
Earnings From Continuing Operations | 53,439 | 50,498 | 42,951 | 38,205 | 41,416 | 39,133 |
Minority Interest in Earnings | -780 | -791 | 92 | -172 | -329 | -357 |
Net Income | 52,659 | 49,707 | 43,043 | 38,033 | 41,087 | 38,776 |
Net Income to Common | 52,659 | 49,707 | 43,043 | 38,033 | 41,087 | 38,776 |
Net Income Growth | 16.13% | 15.48% | 13.17% | -7.43% | 5.96% | 15.85% |
Shares Outstanding (Basic) | 134 | 135 | 137 | 139 | 141 | 143 |
Shares Outstanding (Diluted) | 134 | 135 | 137 | 139 | 141 | 143 |
Shares Change | -1.69% | -1.77% | -1.44% | -1.14% | -1.13% | -1.26% |
EPS (Basic) | 391.56 | 368.26 | 313.26 | 272.82 | 291.36 | 271.88 |
EPS (Diluted) | 391.56 | 368.26 | 313.26 | 272.82 | 291.36 | 271.88 |
EPS Growth | 18.13% | 17.56% | 14.82% | -6.36% | 7.17% | 17.33% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 51,308 | 46,149 | 43,767 | 15,110 | 16,990 | 30,696 |
Free Cash Flow Per Share | 381.51 | 341.90 | 318.53 | 108.39 | 120.48 | 215.22 |
Dividend Per Share | 202.000 | 202.000 | 174.000 | 164.000 | 164.000 | 122.000 |
Dividend Growth | 16.09% | 16.09% | 6.10% | 0% | 34.43% | 17.31% |
Gross Margin | 47.37% | 46.83% | 46.36% | 46.22% | 46.83% | 48.61% |
Operating Margin | 23.35% | 22.73% | 22.61% | 21.26% | 22.93% | 24.50% |
Profit Margin | 18.25% | 17.78% | 17.12% | 16.78% | 18.02% | 18.64% |
Free Cash Flow Margin | 17.78% | 16.51% | 17.41% | 6.67% | 7.45% | 14.76% |
EBITDA | 83,155 | 79,065 | 71,206 | 62,004 | 63,263 | 61,182 |
EBITDA Margin | 28.82% | 28.28% | 28.33% | 27.35% | 27.74% | 29.42% |
D&A For EBITDA | 15,794 | 15,513 | 14,372 | 13,801 | 10,979 | 10,222 |
EBIT | 67,361 | 63,552 | 56,834 | 48,203 | 52,284 | 50,960 |
EBIT Margin | 23.35% | 22.73% | 22.61% | 21.26% | 22.93% | 24.50% |
Effective Tax Rate | 25.16% | 23.37% | 27.78% | 26.22% | 26.83% | 27.74% |